Search results
Tipsheet: As Marlins losses mount, Schumaker can look forward to better opportunities
St. Louis Post-Dispatch· 7 days agoThe undermanned Miami Marlins fell to the San Francisco Giants 3-1 Wednesday for their second loss...
The IMF Spring Meetings: Good news, bad news - BusinessWorld Online
BusinessWorld· 6 days agoTo say the least, it must have been disturbing for financial markets to hear US Federal Reserve...
Oldest choir in Richmond introduces scholars program for high schoolers
Richmond Times-Dispatch· 3 days agoThe Richmond Choral Society is in its 77th season and still going strong. The choir consists of...
Ctrl Alt Ego Overwhelmingly Positive New Game+ news
Indie DB· 5 days agoSince its quiet July 2022 launch Ctrl Alt Ego has been sneaking its way into the public consciousness stream, and it's managing it mostly through word of...
Takeaways from AP report on how the search for the coronavirus origins turned toxic
Newsday· 3 days agoThe Chinese government froze meaningful efforts to trace the origins of the coronavirus pandemic,...
Dying Light 2 Adds 'Nightmare Mode' Two Years After Xbox Launch
Pure Xbox· 7 days agoTechland has dropped a new update today for Dying Light 2, its 2022 zombie-slaying adventure. The...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoHyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer PR Newswire SEOUL, South Korea, April 22, 2024 Clinical trials of Niclosamide-based oral
